Semaglutide: new dawn for diabetics

J Pak Med Assoc. 2023 Mar;73(3):721. doi: 10.47391/JPMA.7558.

Authors

Areeba Memon¹, Moniba Tehrim², Beena Kumari¹

Affiliations

¹ Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
² Karachi Medical and Dental College, Karachi, Pakistan.

PMID: 36932797
DOI: 10.47391/JPMA.7558

No abstract available

Publication types

Letter

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Glucagon-Like Peptides* / therapeutic use
Humans
Hypoglycemic Agents / pharmacology
Hypoglycemic Agents / therapeutic use

Substances

semaglutide
Glucagon-Like Peptides
Hypoglycemic Agents